单细胞RNA测序揭示人脐带间充质干细胞的修复特征
本研究通过单细胞RNA测序分析5例足月供者来源的脐带间充质干细胞(UC-MSCs)及人新生儿真皮成纤维细胞(HNDFs)的转录组,发现UC-MSCs存在祖细胞样和成纤维细胞样亚群;在大鼠高氧诱导新生儿肺损伤模型中,仅祖细胞样UC-MSCs改善肺功能与结构并减轻肺动脉高压,而MHC I类分子高表达与非治疗性细胞及肺滞留减少相关。
要点
- 祖细胞样转录组的UC-MSCs在大鼠高氧肺损伤中提供肺保护,成纤维细胞样亚群无效。
- MHC I类分子高表达与UC-MSCs治疗获益降低及肺滞留减少相关。
- scRNA-seq可用于识别具有更优修复能力的MSC亚群以用于临床。
核心结论
- 具有祖细胞样转录组的UC-MSCs在实验性BPD中提供肺保护,而成纤维细胞样转录组则无此效果。
- MHC I类分子高表达与UC-MSCs治疗获益降低及肺滞留减少相关。
- scRNA-seq可能有助于识别具有更优修复能力的MSC亚群以用于临床应用。
研究设计与样本
- 研究对来自5例足月供者的UC-MSCs及人新生儿真皮成纤维细胞(HNDFs;间充质来源的对照细胞)进行单细胞RNA测序分析。
- 在大鼠高氧诱导新生儿肺损伤模型中测试具有特定转录组的UC-MSCs及对照HNDFs的肺保护效应。
主要发现
- UC-MSCs显示有限的转录组异质性,但与HNDFs不同。
- Gene Ontology富集分析揭示UC-MSCs存在祖细胞样和成纤维细胞样亚群。
- 仅祖细胞样UC-MSCs治疗改善高氧暴露大鼠幼崽的肺功能与结构并减轻肺动脉高压。
- scRNA-seq识别MHC I类分子为非治疗性细胞的分子标志,并与肺滞留减少相关。
临床怎么用
- 在实验性BPD中,祖细胞样转录组的UC-MSCs具有肺保护作用,而成纤维细胞样亚群无效。
- MHC I类分子高表达与UC-MSCs治疗获益降低相关,可作为筛选治疗性细胞的潜在标志。
- scRNA-seq可用于识别具有更优修复能力的MSC亚群,以用于临床转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: The chronic lung disease bronchopulmonary dysplasia (BPD) is the most severe complication of extreme prematurity. BPD results in impaired lung alveolar and vascular development and long-term respiratory morbidity, for which only supportive therapies exist. Umbilical cord-derived mesenchymal stromal cells (UC-MSCs) improve lung structure and function in experimental BPD. Results of clinical trials with MSCs for many disorders do not yet match the promising preclinical studies. A lack of specific criteria to define functionally distinct MSCs persists. Objectives: To determine and correlate single-cell UC-MSC transcriptomic profiles with therapeutic potential. Methods: UC-MSCs from five term donors and human neonatal dermal fibroblasts (HNDFs; control cells of mesenchymal origin) transcriptomes were investigated using single-cell RNA sequencing (scRNA-seq) analysis. The lung-protective effect of UC-MSCs with a distinct transcriptome and control HNDFs was tested in vivo in hyperoxia-induced neonatal lung injury in rats. Measurements and Main Results: UC-MSCs showed limited transcriptomic heterogeneity but were different from HNDFs. Gene Ontology enrichment analysis revealed distinct (progenitor-like and fibroblast-like) UC-MSC subpopulations. Only treatment with progenitor-like UC-MSCs improved lung function and structure and attenuated pulmonary hypertension in hyperoxia-exposed rat pups. Moreover, scRNA-seq identified major histocompatibility complex class I as a molecular marker of nontherapeutic cells and associated with decreased lung retention. Conclusions: UC-MSCs with a progenitor-like transcriptome, but not with a fibroblast-like transcriptome, provide lung protection in experimental BPD. High expression of major histocompatibility complex class I is associated with reduced therapeutic benefit. scRNA-seq may be useful to identify subsets of MSCs with superior repair capacity for clinical application.
引用
- Cyr-Depauw C, Cook DP, Mižik I, et al. Single-Cell RNA Sequencing Reveals Repair Features of Human Umbilical Cord Mesenchymal Stromal Cells. Am J Respir Crit Care Med. 2024. PMID: 38564376. doi:10.1164/rccm.202310-1975OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。